Study Design of a Phase 1/2a Trial with ISIS-DMPKRx for the Treatment of Myotonic Dystrophy Type 1 Thornton, C., Moxley, R., Day, J., Ashizawa, T., Barohn, R., Leung, D., Kissel, J., Johnson, N., Eichinger, K., Hardage, J., Lott, D., Currence, M., Stinson, N., King, W., Hayes, H., Bennett, F., Bishop, K., Mignon, L. LIPPINCOTT WILLIAMS & WILKINS. 2016

View details for Web of Science ID 000411279007396